Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (8429)	1/22/1999 6:21:00 PM
From: aknahow	Respond to of 17367

Cacaito, you made some powerful, and useful post, if anyone paid attention on the ABTI board. Have learned my lesson, no more legs, yes I have it down pat. Two heads! Is that where the expression two heads are better than one, came from? I can't believe that you were the only one that remembered the two heads approach. Impressive. Think, XOMA castrated Faust. He has been totally gunshy since Tharos posted his comments. I am shocked that the U.K. can claim to have reduced mortality by 50% due to their early treatment campaign while the U.S. apparently remains in the dark about what can be done. I thought the glass or bottle test was an important component of the U.K. campaign. Can't get anyone here interested but proof of 50% reduction in mortality would help. Saul Faust, said he would point me in the direction of the statistics if I told him where I worked, I did and he didn't.